SSO 2017 Award Winners

Distinguished Service Award
Presented for outstanding contributions to surgical oncology through service to SSO, research, or enhancing clinical care or health policy. This is the successor to the Society of Surgical Oncology Heritage Award and is funded by The SSO Foundation.

Fabrizio Michelassi, MD
Lewis Atterbury Stimson Professor & Chairman; Surgeon-in-Chief
Weill Cornell Medical College
New York, NY

This Distinguished Service Award recognizes Dr. Michelassi’s tireless efforts to secure approval of the certificate subspecialty in Complex General Surgical Oncology (CGSO).

SSO 2017 Abstract Contest & Award Winners

Colorectal Cancer Research Scholar Award
Each year, the Colon Cancer Challenge Foundation (CCCF) awards a $2,000 grant to provide travel support for a postdoctoral surgical oncology trainee whose paper is accepted for presentation at the SSO Cancer Forum held during the SSO Annual Cancer Symposium. The paper must be primarily focused on colorectal cancer.

Bradley A. Krasnick, MD
Washington University School of Medicine
St. Louis, MO
50: Anti-KRAS siRNA Nanoparticles for Targeted Colorectal Cancer Therapy

Harvey Baker Traveling Fellow Award
Each year The SSO Foundation awards a $1,000 grant to assist in providing travel support for a postdoctoral oncology trainee whose paper is accepted for presentation at the SSO Annual Cancer Symposium.

Jennifer L. Miller-Ocuin, MD
University of Pennsylvania
Pittsburgh, PA
3: Inhibition of Autophagy Improves Pathologic and Biomarker Response to Preoperative Gemcitabine/Nab-Paclitaxel in Potentially Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial

Susan G. Komen Breast Cancer Research Award
The SSO, in partnership with Susan G. Komen®, developed this award in 2016 to recognize excellence in research focused on breast cancer.  The award has been made annually to a postdoctoral breast fellow or newly-trained surgical oncologist interested in breast cancer research whose work is being presented at the SSO Annual Cancer Symposium.

John R. Bergquist, MD, MS, MA
Mayo Clinic
Rochester, MN
8: CPS+EG and Neo-Bioscore are Superior Predictors of Overall Survival After Neoadjuvant Chemotherapy for Breast Cancer: A National Cancer Data Base Validation Study

Poster Competition (2)
Each year, SSO offers two Poster Contest Awards; one for the best Basic/Transitional Research Poster and one for the best Clinical Research Poster. At the event, contest finalist posters are prominently displayed and voted on by attendees. The winner of each category and these were announced during the meeting on Saturday, March 18 during The Great Debates II.

  • Best Clinical Research Poster
    Shirin Muhsen, MD
    Memorial Sloan Kettering Cancer Center
    New York, NY
    PT24: Outcomes of Women with Minimal Volume Ductal Carcinoma in Situ Completely Excised on Core Biopsy
  • Best Basic/Translational Research Poster
    Ibrahim Nassour, MD
    The University of Texas Southwestern Medical Center
    Dallas, TX
    PT181: Arid1a Deletion Results in Intraductal Papillary Mucinous Neoplasm Formation

Resident/Fellow Essay Contest (2)
SSO offers two Resident/Fellow Essay Awards; one for the best Clinical Research paper and one for the best Basic Science Research paper. Contest finalists submit their manuscript in advance of the event and the Society makes its selection following the presentation of all papers at the Annual Scientific Program. The winner was announced during the event on Saturday, March 18. These Awards are supported by an independent grant from The SSO Foundation.

  • Clinical Research Paper
    Georgia Beasley, MD
    The Ohio State University
    Columbus, OH
    30: Multi-Center Study of the Prognostic Value of Sentinel Lymph Node Biopsy in the Management of Recurrent Melanoma
  • Basic Science Research Paper
    There were no finalists in this category this year.

SSO 2017 Award Winner Bios

Fabrizio Michelassi, MD
Lewis Atterbury Stimson Professor & Chairman; Surgeon-in-Chief
Weill Cornell Medical College
New York, NY

Fabrizio Michelassi, MD, FACS, is a world-renowned, board-certified gastrointestinal surgeon with a strong expertise in the surgical treatment of gastrointestinal and pancreatic cancers. He is the Lewis Atterbury Stimson Professor of Surgery and Chairman of Surgery at Weill Cornell Medical College and Surgeon-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center. A prolific author of more than 270 papers, book chapters and abstracts, he has contributed new insight in the surgical treatment of pancreatic and colorectal cancers through clinical trials.

Internationally renowned as an outstanding clinician, researcher and teacher, Dr. Michelassi has been invited to be a visiting professor, deliver keynote lectures and named lectures at more than 80 national and international institutions, and has been an invited lecturer at more than 400 national and international institutions. Dr. Michelassi has earned numerous awards for his innovative contributions to advancing the treatment of digestive cancers, including the Andrew W. Mellon Foundation Award and the American Cancer Society Cancer Development Award. His research on the genetics of gastrointestinal cancer has been funded by the National Institutes of Health and the American Cancer Society.

Dr. Michelassi has served as President of the Society of Surgical Oncology, the Society for the Surgery of the Alimentary Tract, the Western Surgical Society, the Central Surgical Association, the Society of Surgical Chairs, the Illinois Surgical Society and the New York Surgical Society. Dr. Michelassi has served as a Director of the American Board of Surgery since 2006 eventually becoming the Chair of the Surgical Oncology Advisory Council (2009-2011) and the first Surgical Oncology Board Chair (2011-2012).   He has also served as the SSO Governor to the American College of Surgeons eventually becoming the Chair of the Executive Committee of the Board of Governors (2014-2016).  He is currently a Regent of the American College of Surgeons.

Bradley A. Krasnick, MD
Surgical Oncology Research Fellow; PGY3 General Surgery Resident
Washington University School of Medicine
St. Louis, MO

Bradley A. Krasnick, MD, received his BS from the University of Michigan (2010), and completed his medical degree from Wayne State University School of Medicine (2014). He graduated with distinction and was elected into the Alpha Omega Alpha honor society. During this time his research primarily focused on breast cancer, where he worked with surgical oncologist Dr. David Nathanson. After completing two years of general surgery residency at Washington University in St. Louis, Dr. Krasnick is now in his first of three years of dedicated bench research, working with mentor Dr. Ryan Fields. Dr. Krasnick’s primary research interest focuses on the role of nanoparticle based therapy for colorectal cancer. He is specifically interested in patients with metastatic colorectal cancer who harbor a KRAS mutant tumor. He has co-authored 13 peer reviewed publications and over 20 posters/presentations. In his free time, he enjoys skiing, reading, cooking, and spending time with family and friends. After general surgery residency, he plans to complete a colorectal or surgical oncology fellowship, and hopes to continue to pursue translational nanoparticle based oncology research in an academic setting.

Jennifer L. Miller-Ocuin, MD
General Surgery Resident; Postdoctoral Fellow
University of Pennsylvania
Pittsburgh, PA

Jennifer Miller-Ocuin, MD completed her undergraduate degree at the Pennsylvania State University, graduating in the top 0.5% of her class and as the top performing student in her major. She completed her medical training at the Pennsylvania State University College of Medicine with AOA and Gold Humanism Honors. Dr. Miller-Ocuin has completed two years of categorical General Surgery residency at the Penn State Milton S. Hershey Medical Center prior to earning a T32 Research Scholar position at the University of Pittsburgh in the laboratory of Dr. Herbert J. Zeh, III. Her research has focused on understanding the role of autophagy inhibition in altering the immune profile in pancreatic cancer. Following completion of her clinical training, she plans to pursue fellowship training in Surgical Oncology.

John R. Bergquist, MD, MS, MA
General Surgery Resident
Mayo Clinic
Rochester, MN

Dr. Bergquist is a 3rd year general surgery resident at Mayo Clinic in Rochester, MN. His clinical interests include breast, colorectal, and hepatobiliary surgical oncology. He worked in the lab for 2 years performing translational research utilizing pancreatic and biliary patient-derived xenografts and has been an active investigator of surgical outcomes in particular utilizing the National Cancer Database to investigate staging systems for breast, pancreatic, biliary, and colorectal cancers. Prior to his career in medicine Dr. Bergquist worked for 10 years as an engineer for Science Applications International Corporation. His engineering specialty was computational fluid dynamics. Dr. Bergquist has a strong interest in applying his training and experience as an engineer to both research and clinical work.

Shirin Muhsen, MD
Breast Surgical Oncology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY

Shirin Muhsen, MD is currently a Breast Surgical Oncology fellow at Memorial Sloan Kettering Cancer Center, New York. She completed both her medical and general surgical training at the American University of Beirut Medical Center, Lebanon. Before starting her surgical residency she dedicated two years to research as a research fellow at Memorial Sloan Kettering Cancer Center, New York.

Ibrahim Nassour, MD
The University of Texas Southwestern Medical Center
Dallas, TX

I received my medical degree at the American University of Beirut, graduating with AOA and first in my class. I next completed a postdoctoral research fellowship at the University of Pittsburgh Medical Center, then started my training at Johns Hopkins where I completed my first two years of general surgery residency. I then moved to the University of Texas Southwestern Medical Center as a PGY3 categorical resident. Here, I am completing a two-year postdoctoral fellowship under the mentorship of Dr. Sam Wang and Dr. Hao Zhu and pursuing a Masters of Clinical Science. I am interested in the epigenetics of pancreas cancer and intraductal papillary mucinous neoplasms. My long-term goal is to become a surgical oncologist working in an academic center. 

Georgia Beasley, MD
Surgical Oncology Research Fellow
The Ohio State University
Columbus, OH

I am currently a second-year fellow in surgical oncology at the Ohio State University. My main focus of research and clinical interest is melanoma.

  •  
    • SSO Exposition Management
    • SPARGO, Inc.
    • Toll Free (800) 564-4220
    • Phone:  (703) 631-6200
    • Fax (703) 563-2691
    • Emailssoexhibits@spargoinc.com